Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
5.74
Dollar change
-0.15
Percentage change
-2.55
%
IndexRUT P/E- EPS (ttm)-2.33 Insider Own18.70% Shs Outstand46.68M Perf Week-5.75%
Market Cap268.12M Forward P/E- EPS next Y-1.27 Insider Trans0.05% Shs Float37.98M Perf Month-21.90%
Enterprise Value173.43M PEG- EPS next Q-0.45 Inst Own76.90% Short Float9.42% Perf Quarter9.96%
Income-95.66M P/S2.06 EPS this Y-126.82% Inst Trans0.32% Short Ratio4.85 Perf Half Y26.43%
Sales130.20M P/B0.85 EPS next Y44.20% ROA-22.37% Short Interest3.58M Perf YTD-9.75%
Book/sh6.74 P/C1.99 EPS next 5Y-1.72% ROE-29.28% 52W High8.77 -34.55% Perf Year-28.78%
Cash/sh2.89 P/FCF- EPS past 3/5Y14.43% 9.19% ROIC-27.63% 52W Low4.05 41.73% Perf 3Y-57.73%
Dividend Est.- EV/EBITDA- Sales past 3/5Y7.52% 19.36% Gross Margin54.28% Volatility7.22% 7.60% Perf 5Y-93.37%
Dividend TTM- EV/Sales1.33 EPS Y/Y TTM-149.18% Oper. Margin-74.61% ATR (14)0.48 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.31 Sales Y/Y TTM-2.69% Profit Margin-73.47% RSI (14)36.95 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio3.02 EPS Q/Q-235.04% SMA20-11.42% Beta1.07 Target Price7.50
Payout- Debt/Eq0.13 Sales Q/Q12.34% SMA50-15.96% Rel Volume0.38 Prev Close5.89
Employees471 LT Debt/Eq0.10 EarningsNov 10 AMC SMA200-2.07% Avg Volume737.73K Price5.74
IPODec 07, 2017 Option/ShortYes / Yes EPS/Sales Surpr.-59.56% 6.76% Trades Volume278,939 Change-2.55%
Date Action Analyst Rating Change Price Target Change
Aug-11-25Downgrade Canaccord Genuity Buy → Hold $5
Feb-01-24Initiated Scotiabank Sector Outperform $30
Sep-25-23Upgrade Canaccord Genuity Hold → Buy $25 → $32
Aug-08-23Upgrade SVB Securities Market Perform → Outperform $30
May-23-23Upgrade Goldman Neutral → Buy $13 → $27
Aug-15-22Downgrade Canaccord Genuity Buy → Hold $40 → $12
Aug-09-22Downgrade SVB Leerink Outperform → Mkt Perform $35 → $15
Aug-09-22Downgrade Cowen Outperform → Market Perform $38 → $18
Mar-02-22Upgrade Goldman Sell → Neutral $40
Oct-15-21Resumed Cowen Outperform
Feb-04-26 12:57PM
Feb-03-26 08:33AM
Jan-21-26 08:33AM
Jan-16-26 04:01PM
Jan-08-26 04:30PM
07:30AM Loading…
Dec-22-25 07:30AM
Nov-20-25 04:15PM
Nov-17-25 05:30PM
Nov-11-25 12:02AM
Nov-10-25 05:10PM
04:01PM
Nov-07-25 07:35AM
07:22AM
Nov-03-25 07:00AM
Oct-02-25 12:00PM
04:30PM Loading…
Aug-21-25 04:30PM
Aug-12-25 09:35AM
Aug-11-25 07:00AM
Aug-07-25 06:35PM
04:06PM
Aug-04-25 04:02PM
09:30AM
Jul-28-25 07:00AM
Jul-24-25 08:45AM
Jul-11-25 05:00PM
Jul-08-25 09:07AM
Jun-23-25 07:30AM
Jun-11-25 08:00AM
Jun-06-25 09:41AM
May-23-25 02:21PM
09:10AM Loading…
09:10AM
May-13-25 03:09AM
May-12-25 05:10PM
04:01PM
May-09-25 09:42AM
May-07-25 07:40PM
May-05-25 07:00AM
Apr-30-25 08:00AM
Apr-29-25 07:00AM
Apr-17-25 08:30AM
Apr-14-25 08:00AM
Apr-07-25 08:15AM
Apr-02-25 09:41AM
Apr-01-25 01:00AM
Mar-24-25 11:03AM
Mar-19-25 04:10PM
Mar-18-25 09:18AM
03:01AM
Mar-17-25 04:01PM
04:00PM
04:00PM
Mar-13-25 01:00PM
Mar-11-25 08:00AM
Mar-03-25 08:00AM
06:00AM
Feb-18-25 03:40PM
Jan-14-25 07:00AM
Jan-10-25 07:00AM
Jan-06-25 09:30AM
Jan-02-25 04:26PM
Dec-27-24 04:33AM
Dec-17-24 06:59AM
Nov-22-24 05:00PM
07:54AM
Nov-21-24 07:00AM
Nov-13-24 02:18AM
Nov-12-24 04:01PM
Nov-11-24 07:14AM
Nov-05-24 04:00PM
Oct-28-24 04:30PM
Oct-09-24 05:55PM
Oct-02-24 04:00PM
Sep-30-24 04:00PM
Aug-29-24 04:00PM
Aug-19-24 04:32PM
Aug-15-24 07:18PM
Aug-08-24 05:10PM
04:00PM
Aug-06-24 04:00PM
Jul-31-24 04:00PM
Jul-29-24 10:00AM
08:00AM
Jun-17-24 04:00PM
Jun-05-24 04:00PM
May-22-24 04:00PM
May-15-24 09:55AM
May-09-24 04:45PM
03:10AM
May-07-24 09:00PM
05:10PM
04:00PM
Apr-29-24 04:00PM
11:13AM
Mar-21-24 05:30PM
Mar-06-24 09:50AM
Mar-04-24 09:00AM
Mar-03-24 08:16AM
Mar-01-24 09:26AM
Feb-29-24 05:10PM
04:00PM
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sriram VandanaChief Financial OfficerSep 12 '25Buy4.794,15019,87887,200Sep 17 10:24 AM
WALT DAVID RDirectorJun 13 '25Buy6.14123,990760,8031,866,933Jun 13 04:39 PM
WALT DAVID RDirectorJun 12 '25Buy6.2336,010224,1661,742,943Jun 13 04:39 PM
Toloue MasoudPresident & CEOJun 09 '25Buy5.4245,900248,723518,922Jun 10 04:08 PM
WALT DAVID RDirectorJun 06 '25Buy5.43131,869716,5761,628,802Jun 09 05:44 PM
WALT DAVID RDirectorJun 09 '25Buy5.3478,131417,2201,706,933Jun 09 05:44 PM
DONNELLY WILLIAM PDirectorJun 06 '25Buy5.4493,113506,348139,094Jun 09 05:10 PM
Last Close
Feb 13  •  04:00PM ET
93.76
Dollar change
+0.60
Percentage change
0.64
%
TROW T. Rowe Price Group Inc daily Stock Chart
IndexS&P 500 P/E10.14 EPS (ttm)9.25 Insider Own1.82% Shs Outstand218.56M Perf Week-0.87%
Market Cap20.46B Forward P/E9.23 EPS next Y10.16 Insider Trans-0.18% Shs Float214.27M Perf Month-11.61%
Enterprise Value18.75B PEG5.92 EPS next Q2.46 Inst Own84.74% Short Float9.55% Perf Quarter-10.51%
Income2.04B P/S2.80 EPS this Y3.47% Inst Trans-0.27% Short Ratio10.39 Perf Half Y-14.03%
Sales7.31B P/B1.89 EPS next Y1.01% ROA14.41% Short Interest20.46M Perf YTD-8.42%
Book/sh49.69 P/C6.06 EPS next 5Y1.56% ROE19.21% 52W High118.22 -20.69% Perf Year-12.57%
Cash/sh15.48 P/FCF8.27 EPS past 3/5Y11.32% -1.52% ROIC18.07% 52W Low77.85 20.44% Perf 3Y-22.74%
Dividend Est.5.17 (5.51%) EV/EBITDA6.26 Sales past 3/5Y4.08% 3.34% Gross Margin78.89% Volatility2.47% 2.64% Perf 5Y-41.65%
Dividend TTM5.08 (5.42%) EV/Sales2.56 EPS Y/Y TTM0.90% Oper. Margin35.40% ATR (14)2.97 Perf 10Y40.95%
Dividend Ex-DateMar 16, 2026 Quick Ratio3.10 Sales Y/Y TTM3.12% Profit Margin27.84% RSI (14)35.26 Recom3.53
Dividend Gr. 3/5Y1.91% 7.13% Current Ratio3.10 EPS Q/Q3.42% SMA20-7.27% Beta1.56 Target Price99.92
Payout54.95% Debt/Eq0.04 Sales Q/Q6.01% SMA50-9.42% Rel Volume1.36 Prev Close93.16
Employees7773 LT Debt/Eq0.04 EarningsFeb 04 BMO SMA200-7.95% Avg Volume1.97M Price93.76
IPOApr 02, 1986 Option/ShortYes / Yes EPS/Sales Surpr.-0.68% 0.31% Trades Volume2,668,214 Change0.64%
Date Action Analyst Rating Change Price Target Change
Oct-03-25Initiated BMO Capital Markets Market Perform $108
Sep-12-24Initiated Wells Fargo Equal Weight $109
Aug-27-24Initiated Barclays Underweight $99
Apr-11-24Upgrade Keefe Bruyette Underperform → Mkt Perform $106 → $120
Apr-08-24Upgrade TD Cowen Sell → Hold $92 → $114
Jan-08-24Downgrade Wells Fargo Equal Weight → Underweight $95 → $105
Jan-04-24Initiated TD Cowen Underperform $88
Oct-31-23Upgrade Citigroup Sell → Neutral $100 → $95
May-19-23Initiated Citigroup Sell $98
Dec-15-22Initiated Wells Fargo Equal Weight $125
Feb-14-26 08:56AM
Feb-13-26 01:33PM
Feb-12-26 01:12PM
Feb-11-26 11:44AM
10:00AM
10:00AM Loading…
10:00AM
08:30AM
12:43AM
Feb-10-26 10:51AM
10:06AM
Feb-09-26 04:09PM
08:37AM
Feb-06-26 11:29AM
11:12AM
Feb-05-26 07:56PM
11:26AM Loading…
11:26AM
12:35AM
Feb-04-26 09:08PM
03:36PM
02:02PM
12:52PM
11:12AM
10:52AM
10:03AM
09:30AM
09:11AM
08:46AM
08:25AM
07:44AM
07:28AM
07:00AM Loading…
07:00AM
Feb-03-26 04:00PM
11:52AM
09:40AM
07:53AM
05:49AM
Feb-02-26 10:11PM
06:04PM
11:17AM
09:15AM
08:29AM
Feb-01-26 07:47AM
Jan-29-26 11:35PM
10:21AM
10:00AM
Jan-28-26 11:30AM
10:00AM
05:30AM
Jan-25-26 02:07AM
Jan-24-26 09:00AM
Jan-23-26 12:57PM
Jan-22-26 01:21PM
09:08AM
08:45AM
05:24AM
Jan-21-26 06:49PM
03:06PM
10:32AM
08:26AM
06:11AM
06:06AM
05:06AM
12:31AM
Jan-19-26 06:02PM
11:00AM
Jan-18-26 12:00PM
Jan-15-26 06:15PM
12:10PM
08:55AM
08:30AM
Jan-14-26 09:59AM
09:45AM
Jan-13-26 07:00AM
Jan-12-26 09:40AM
06:00AM
Jan-09-26 06:15PM
01:48PM
09:57AM
Jan-08-26 05:38PM
01:08PM
08:30AM
06:10AM
Jan-07-26 12:23PM
09:50AM
Jan-06-26 12:55PM
06:15AM
Jan-05-26 08:00PM
Jan-04-26 12:30AM
Jan-03-26 06:30AM
Dec-31-25 09:43AM
Dec-30-25 10:09AM
Dec-26-25 11:10PM
Dec-23-25 05:28PM
Dec-22-25 06:15PM
Dec-18-25 09:40AM
Dec-17-25 09:50AM
Dec-16-25 12:22PM
Dec-15-25 03:46PM
09:30AM
Dec-11-25 11:35PM
T. Rowe Price Group, Inc. engages in the provision of investment management services. It provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. The firm invests in the public equity and fixed income markets across the globe. The company was founded by Thomas Rowe Price Jr. in 1937 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Husain ArifVPDec 10 '25Sale101.964,260434,33647,102Dec 11 01:45 PM
Husain ArifOfficerDec 10 '25Proposed Sale102.064,260434,760Dec 10 04:01 PM
MacLellan Robert F.DirectorSep 22 '25Option Exercise72.824,417321,65150,425Sep 23 08:48 AM
MacLellan Robert F.DirectorSep 22 '25Sale105.013,090324,46647,335Sep 23 08:48 AM
ROBERT MACLELLANDirectorSep 22 '25Proposed Sale105.013,090324,466Sep 22 04:02 PM
Page SebastienVice PresidentJun 18 '25Option Exercise69.0217,0591,177,49578,675Jun 20 09:49 AM
Sawyer Dorothy CVPJun 11 '25Sale95.432,000190,86044,789Jun 12 09:20 AM
Sawyer Dorothy CVice PresidentJun 11 '25Proposed Sale94.982,000189,960Jun 11 11:18 AM
Hiebler Jessica MPrincipal Accounting OfficerMay 12 '25Sale96.9896893,87913,611May 13 11:16 AM
Hiebler Jessica MOfficerMay 12 '25Proposed Sale96.8696893,760May 13 09:39 AM
MacLellan Robert F.DirectorMar 31 '25Option Exercise81.144,417358,40546,934Apr 01 12:02 PM
MacLellan Robert F.DirectorMar 31 '25Sale91.563,955362,12042,979Apr 01 12:02 PM
ROBERT F. MACLELLANDirectorMar 31 '25Proposed Sale91.563,955362,120Mar 31 04:04 PM
Last Close
Feb 13  •  04:00PM ET
98.52
Dollar change
+4.31
Percentage change
4.57
%
IR Ingersoll-Rand Inc daily Stock Chart
IndexS&P 500 P/E67.81 EPS (ttm)1.45 Insider Own0.21% Shs Outstand395.11M Perf Week0.02%
Market Cap38.93B Forward P/E25.44 EPS next Y3.87 Insider Trans-26.09% Shs Float394.21M Perf Month14.57%
Enterprise Value42.53B PEG3.09 EPS next Q0.75 Inst Own105.87% Short Float4.36% Perf Quarter26.78%
Income581.40M P/S5.09 EPS this Y5.77% Inst Trans1.71% Short Ratio5.03 Perf Half Y22.84%
Sales7.65B P/B3.82 EPS next Y9.61% ROA3.20% Short Interest17.18M Perf YTD24.36%
Book/sh25.80 P/C31.17 EPS next 5Y8.24% ROE5.74% 52W High100.00 -1.48% Perf Year6.45%
Cash/sh3.16 P/FCF31.90 EPS past 3/5Y-0.70% - ROIC3.91% 52W Low65.61 50.16% Perf 3Y71.58%
Dividend Est.0.05 (0.05%) EV/EBITDA21.38 Sales past 3/5Y8.95% 14.00% Gross Margin38.54% Volatility3.95% 3.29% Perf 5Y124.32%
Dividend TTM0.08 (0.08%) EV/Sales5.56 EPS Y/Y TTM-29.38% Oper. Margin19.40% ATR (14)3.21 Perf 10Y-
Dividend Ex-DateMar 04, 2026 Quick Ratio1.49 Sales Y/Y TTM5.75% Profit Margin7.60% RSI (14)65.21 Recom2.37
Dividend Gr. 3/5Y58.74% - Current Ratio2.06 EPS Q/Q18.54% SMA207.59% Beta1.28 Target Price96.97
Payout5.52% Debt/Eq0.47 Sales Q/Q10.14% SMA5015.08% Rel Volume2.04 Prev Close94.21
Employees21000 LT Debt/Eq0.47 EarningsFeb 12 AMC SMA20020.19% Avg Volume3.42M Price98.52
IPOMay 12, 2017 Option/ShortYes / Yes EPS/Sales Surpr.5.90% 2.28% Trades Volume6,975,390 Change4.57%
Date Action Analyst Rating Change Price Target Change
Jul-14-25Downgrade Melius Buy → Hold $93
Nov-18-24Downgrade Stifel Buy → Hold $112 → $107
Nov-13-24Resumed UBS Buy $102 → $124
Sep-06-24Initiated Morgan Stanley Equal-Weight $97
Jun-21-24Resumed Jefferies Buy $110
Mar-12-24Initiated Exane BNP Paribas Neutral $92
Feb-20-24Downgrade Evercore ISI Outperform → In-line $81 → $89
Oct-24-23Upgrade Stifel Hold → Buy $73
May-09-23Upgrade Evercore ISI In-line → Outperform $71
Aug-05-22Downgrade Deutsche Bank Buy → Hold $50 → $52
Feb-13-26 05:41PM
03:25PM
02:01PM
12:33PM
11:51AM
11:05AM Loading…
11:05AM
08:30AM
Feb-12-26 06:00PM
05:30PM
04:45PM
04:36PM
04:10PM
Feb-11-26 04:30PM
Feb-10-26 10:06PM
10:00AM
09:15AM Loading…
Feb-09-26 09:15AM
Feb-06-26 07:40AM
Feb-05-26 10:00AM
Feb-04-26 06:16AM
Feb-03-26 07:34PM
Feb-02-26 10:23AM
10:21AM
Jan-30-26 11:23AM
10:34AM
Jan-27-26 08:30AM
Jan-20-26 11:35PM
Jan-16-26 09:17AM
Jan-12-26 04:30PM
Jan-11-26 11:03PM
Jan-06-26 11:21AM
04:30PM Loading…
Jan-05-26 04:30PM
Dec-28-25 11:44AM
Dec-22-25 08:30AM
Dec-17-25 08:30AM
Dec-15-25 10:44AM
Dec-14-25 11:35PM
Dec-05-25 11:30AM
09:31AM
Dec-02-25 10:22AM
Nov-20-25 04:15PM
Nov-13-25 10:34PM
Nov-12-25 11:54AM
Nov-06-25 12:36AM
Nov-03-25 04:30PM
08:31AM
Nov-02-25 06:01AM
Oct-31-25 07:35PM
03:11PM
03:02PM
01:17PM
Oct-30-25 06:00PM
05:30PM
04:55PM
04:25PM
04:15PM
09:21AM
Oct-29-25 09:22AM
09:20AM
09:15AM
Oct-28-25 11:20PM
12:50PM
Oct-23-25 04:30PM
10:00AM
Oct-15-25 08:23AM
Oct-14-25 11:32PM
Oct-13-25 12:15PM
12:02AM
Oct-10-25 04:30PM
Oct-02-25 10:15AM
Oct-01-25 12:00PM
11:40AM
Sep-30-25 09:05AM
Sep-15-25 11:40AM
12:37AM
Sep-11-25 09:40AM
Sep-08-25 12:32AM
Sep-05-25 05:11PM
Aug-29-25 11:40AM
Aug-21-25 08:00AM
Aug-18-25 09:23AM
Aug-12-25 11:16PM
11:07PM
Aug-05-25 11:40AM
Aug-04-25 08:30AM
Aug-02-25 03:05AM
Aug-01-25 12:03PM
11:48AM
10:49AM
06:19AM
Jul-31-25 07:16PM
07:00PM
05:40PM
04:47PM
04:30PM
09:18AM
Jul-30-25 11:17AM
09:21AM
Jul-29-25 11:14PM
Jul-24-25 04:30PM
01:19PM
Ingersoll Rand Inc. engages in the provision of services and solutions through air, fluid, energy, and medical technologies. It operates through the Industrial Technologies and Services, and Precision and Science Technologies segments. The Industrial Technologies and Services segment provides compressor, vacuum, blower solutions, and industrial technologies such as power tools and lifting equipment. The Precision and Science Technologies segment includes fluid management solutions such as precision liquid and gas pumps, and niche compression technologies. The company was founded in 1872 and is headquartered in Davidson, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reynal VicenteSee RemarksFeb 11 '26Option Exercise10.614404,668230,108Feb 13 06:03 PM
Reynal VicenteSee RemarksFeb 11 '26Sale100.0044044,000229,668Feb 13 06:03 PM
Reynal VicenteOfficerFeb 13 '26Proposed Sale100.3955,8705,608,800Feb 13 04:13 PM
Reynal VicenteOfficerFeb 11 '26Proposed Sale100.0044044,000Feb 11 04:39 PM
Reynal VicenteSee RemarksFeb 04 '26Option Exercise10.6190,281957,881283,467Feb 05 07:18 PM
Reynal VicenteSee RemarksFeb 03 '26Option Exercise10.619,719103,119202,905Feb 05 07:18 PM
Reynal VicenteSee RemarksFeb 04 '26Sale97.9290,2818,840,742193,186Feb 05 07:18 PM
Reynal VicenteSee RemarksFeb 03 '26Sale94.009,719913,625193,186Feb 05 07:18 PM
Reynal VicenteOfficerFeb 04 '26Proposed Sale97.9290,2818,840,750Feb 04 04:06 PM
Reynal VicenteOfficerFeb 03 '26Proposed Sale94.009,719913,630Feb 03 04:43 PM
Reynal VicenteSee RemarksJan 16 '26Option Exercise10.61191,0002,026,510384,186Jan 21 06:01 PM
Reynal VicenteSee RemarksJan 16 '26Sale88.12191,00016,830,920193,186Jan 21 06:01 PM
Reynal VicenteOfficerJan 16 '26Proposed Sale88.12191,00016,829,997Jan 16 04:20 PM
Scheske Michael JVP, Chief Accounting OfficerDec 01 '25Sale80.631,477119,08612,153Dec 03 06:00 PM
Scheske Michael JOfficerDec 01 '25Proposed Sale80.631,477119,086Dec 01 01:59 PM
Forsee Gary DFormer DirectorAug 27 '25Proposed Sale80.5019,0551,533,868Aug 27 03:34 PM
Reynal VicenteSee RemarksMay 20 '25Option Exercise10.6138,657410,151231,843May 22 06:52 PM
Reynal VicenteSee RemarksMay 20 '25Sale83.0338,6573,209,768193,186May 22 06:52 PM
Reynal VicenteOfficerMay 20 '25Proposed Sale83.0338,6573,209,772May 20 04:13 PM
Hepding Elizabeth MeloySee RemarksMay 14 '25Sale83.783,500293,23010,986May 15 08:26 PM
Schiesl Andrew RSee RemarksMay 13 '25Sale84.9011,500976,31621,964May 15 08:26 PM
Hepding Elizabeth MeloyOfficerMay 14 '25Proposed Sale83.783,500293,230May 14 01:26 PM
Schiesl Andrew ROfficerMay 13 '25Proposed Sale84.9011,500976,317May 13 02:58 PM
Schiesl Andrew RSee RemarksFeb 18 '25Sale87.0513,2281,151,49730,846Feb 20 05:54 PM
Schiesl Andrew ROfficerFeb 18 '25Proposed Sale87.0513,2281,151,495Feb 18 11:21 AM